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Imaging	the	visual	system:	from	the	eye	to	the	brain	
	
Imaging	technologies	have	revolutionized	the	study	of	human	anatomy	and	
physiology.	Nowhere	is	this	more	evident	than	in	the	vision	sciences,	where	imaging	
has	provided	unprecedented	insights	into	the	structure	and	function	of	the	entire	
visual	pathway	in	vivo.	Ocular	and	retinal	imaging	techniques	such	as	optical	
coherence	tomography	(OCT)1,	2	have	become	established	clinical	tools,	providing	
highly	detailed	images	of	ocular	structures	that	are	now	used	routinely	to	support	
the	diagnosis	and	management	of	ocular	disease.		The	expanding	scope	of	
measurements	possible	with	ocular	imaging	technology	is	resulting	in	even	more	
accurate	diagnostic	and	prognostic	clinical	instruments	and	progressing	our	
understanding	of	the	eye’s	structural	and	functional	properties	(Morgan,	this	issue).			
	
On	the	other	hand,	brain	imaging	technologies	such	as	functional	magnetic	
resonance	imaging3,	4	and	diffusion	tensor	tractography5	are	not	yet	widely	utilized	
in	the	clinical	management	of	visual	disorders.	This	is	likely	to	change.	There	is	
increasing	evidence	that	the	impact	of	ocular	disease	on	visual	function	cannot	be	
fully	understood	without	considering	associated	changes	in	the	structure	and	
function	of	the	brain	(Brown	et	al.,	this	issue).	Furthermore,	attempts	to	restore	
vision	using	electrical	prosthetics6‐8	or	regenerative	medicine9	require	an	
understanding	of	the	entire	visual	pathway	in	patients	with	vision	loss.	For	example,	
any	neurodegenerative	effects	of	long‐term	visual	cortex	deafferentation	will	limit	
the	extent	to	which	vision	can	be	recovered	when	retinal	input	to	the	brain	is	
restored.	Therefore	future	advances	in	the	field	of	vision	restoration	are	likely	to	
rely	critically	on	information	from	a	combination	of	both	eye	and	brain	imaging	
techniques.	
	
This	feature	issue	had	two	main	goals.	The	first	was	to	identify	new	imaging	
technologies	and	recent	progress	in	established	imaging	methodologies	that	can	be	
applied	to	the	visual	system.	The	second	was	to	highlight	advances	in	our	
understanding	of	the	visual	system	and	visual	disorders	that	have	been	achieved	
through	the	use	of	imaging	techniques.	These	broad	goals	allowed	us	to	assemble	a	
collection	of	papers	that	span	the	entire	visual	system	from	the	cornea	to	the	
extrastriate	visual	cortex.		
	
The	feature	issue	begins	with	two	invited	reviews	that	together	provide	
comprehensive	overviews	of	both	retinal	and	brain	imaging.	The	first	review,	by	
Jessica	Morgan,	describes	recent	developments	in	retinal	imaging	resulting	from	the	
use	of	novel	OCT	techniques,	adaptive	optics	and	their	combination.	These	
techniques	allow	for	detailed,	cellular	level	imaging	of	retinal	layers	and	
vasculature,	visualization	of	the	photoreceptor	mosaic	(both	cones	and	rods)	and	
even	perimetry	at	the	level	of	individual	photoreceptors.	Morgan	also	describes	the	
exciting	possibility	of	high‐resolution	functional	imaging	of	the	retina.	These	cutting	
edge	technological	advances	in	retinal	imaging	have	direct	implications	for	the	early	
detection	of	retinal	dysfunction	and	improved	assessment	of	treatment	outcomes.		
	
The	second	review,	by	Brown	et	al.,	deals	with	the	application	of	structural,	
functional	and	spectroscopic	magnetic	resonance	imaging	(MRI)	techniques	to	the	
study	of	vision	disorders.	The	visual	system	is	particularly	amenable	to	functional	
MRI	(fMRI)	because	it	is	relatively	straightforward	to	present	participants	with	
well‐controlled	stimuli	for	psychophysics	within	the	scanner	environment.	In	fact,	
the	very	first	human	functional	magnetic	resonance	imaging	(fMRI)	studies	involved	
measurements	of	visual	cortex	activation3,	4,	10.	It	is	perhaps	not	surprising	then,	that	
fMRI	has	been	used	extensively	to	study	the	functional	organization	of	the	human	
visual	system.		Precisely	organized	retinotopic	maps	have	been	visualized	within	the	
primary	and	extrastriate	visual	cortex11‐14	as	well	as	in	thalamic	areas	such	as	the	
pulvinar15.	Recent	advances	in	retinotopic	mapping	techniques	have	even	allowed	
for	the	estimation	of	average	receptive	field	size	within	specific	regions	of	the	visual	
cortex16.	In	more	general	terms,	structural	and	functional	MRI	has	advanced	our	
understanding	of	visual	pathway	disease	mechanisms	and	the	extent	to	which	the	
brain	can	reorganize	in	response	to	impaired	visual	input.			
	
Brown	et	al.	provide	an	introduction	to	structural	and	functional	brain	imaging	
techniques	as	well	as	a	technique	called	magnetic	resonance	spectroscopy	that	
enables	the	measurement	of	metabolite	concentration	in	targeted	brain	areas.	They	
then	describe	studies	that	have	used	these	techniques	to	unveil	the	cortical	and	
subcortical	effects	of	anophthalmia,	macular	degeneration,	retinitis	pigmentosa,	
glaucoma,	albinism	and	amblyopia	in	humans.	It	is	clear	from	this	review	that	the	
impact	of	ocular	disease	and	dysfunction	on	the	visual	system	does	not	end	at	the	
eye.		
	
Both	review	papers	highlight	the	remarkably	rapid	technical	advances	that	imaging	
technologies	have	undergone,	and	the	substantial	contributions	that	imaging	has	
made	to	vision	science.	It	is	also	evident	from	both	reviews	that	significant	
breakthroughs	in	the	clinical	application	of	imaging	technologies	are	imminent.	This	
theme	is	reflected	in	the	original	research	papers	included	in	the	feature	issue.		
	
The	first	two	papers	relate	to	anterior	eye‐imaging	technologies.	Iskander	et	al.	
report	on	the	Eye	Surface	Profiler:	a	device	that	utilizes	fourier	transform	
profilometry	to	measure	the	topography	of	the	anterior	eye	in	high	resolution,	
extending	across	cornea,	limbus	and	sclera.	The	possibility	of	accurately	mapping	
the	topography	of	the	limbus	and	sclera	provides	exciting	new	opportunities	to	
further	our	understanding	of	the	anterior	eye’s	topography,	which	in	turn	has	the	
potential	to	impact	upon	contact	lens	fitting	and	design.			
	
In	order	to	properly	interpret	the	exceptionally	precise	anterior	eye	measurements	
that	can	be	achieved	with	contemporary	OCT	techniques,	it	is	essential	to	
understand	the	normal	physiological	factors	that	influence	anterior	eye	structure.	
Read	et	al.	highlight	this	issue	by	showing	that	scleral	and	conjunctival	thicknesses	
vary	significantly	throughout	the	24	hour	sleep/wake	cycle.	This	result	
demonstrates	the	ability	of	high	resolution	imaging	to	reveal	new	physiological	
changes,	and	underscores	the	importance	of	considering	normal	variations	in	ocular	
tissues	when	interpreting	anterior	eye	measurements.	
	
Moving	from	the	anterior	eye	to	the	retina,	Chui	et	al.	report	the	use	of	adaptive	
optics	scanning	light	ophthalmoscopy	(AOSLO)	to	document	the	remodeling	of	the	
retinal	microvasculature	in	a	patient	with	diabetic	retinopathy.	The	longitudinal	
changes	in	microvasculature	that	can	be	detected	using	this	technique	are	striking	
and	demonstrate	the	potential	of	AOSLO	to	track	disease	processes	and	quantify	
treatment	outcomes.		
	
The	next	two	papers	highlight	the	utility	of	imaging	technologies	for	the	detection	of	
ocular	disease.	Ly	et	al.	review	the	use	of	infrared	reflectance	imaging	to	detect	age	
related	macular	degeneration	(AMD)	and	to	differentiate	between	different	
phenotypes	of	the	disease.		The	authors	also	provide	case	images	to	guide	clinicians	
in	the	use	infrared	reflectance	imaging	for	the	diagnosis	of	AMD.	Pang	and	Franz	
demonstrate	that	the	Heidelberg	Retinal	Tomograph	(HRT)	has	higher	sensitivity	
and	specificity	for	detecting	congenital	optic	nerve	hypoplasia	than	the	standard	
measurement	of	disc‐to‐macula/disc	diameter	ratio.	An	optimal	HRT	disc	area	
cutoff	value	for	distinguishing	between	optic	nerve	hypoplasia	and	a	healthy	optic	
nerve	head	is	also	provided.	
	
The	final	set	of	three	papers	deal	with	the	use	of	MRI	techniques	to	assess	the	
impact	of	visual	disorders	on	the	brain.		Two	of	these	papers	use	functional	MRI	to	
address	a	fundamental	question	in	visual	neuroscience:	does	the	human	visual	
system	have	sufficient	plasticity	to	“remap”	in	response	to	disease	or	injury?	
Fracasso	et	al.	investigate	the	structure	of	retinotopic	maps	in	a	patient	with	
congenital	hemihydranencephaly,	a	disorder	that	causes	the	complete	absence	of	
one	hemisphere	due	to	abnormal	prenatal	cortical	development.	The	absence	of	one	
hemisphere	represents	an	extreme	challenge	to	the	visual	system	because	the	entire	
cortical	representation	of	one	visual	hemifield	is	absent.	However,	visual	field	
testing	revealed	that	the	patient’s	vision	extended	into	the	left	visual	field	despite	
the	absence	of	a	right	cerebral	hemisphere.	Subsequent	high‐field	fMRI	
measurements	showed	that	the	remaining	right	hemisphere	contained	population	
receptive	fields	that	encoded	both	the	left	and	right	hemifields.	This	is	a	dramatic	
demonstration	of	extensive	visual	cortex	plasticity	occurring	in	response	to	a	
prenatal	developmental	abnormality.		
	
In	contrast	to	Fracasso	et	al’s	finding,	Haak	et	al.	report	an	absence	of	cortical	
reorganization	following	visual	system	damage.	The	key	difference	is	that	while	
Fracasso	et	al’s	patient	had	an	abnormal	visual	pathway	from	birth,	the	patients	
studied	by	Haak	et	al.	lost	vision	later	in	life	due	to	juvenile	macular	degeneration.	
Despite	extended	periods	of	vision	loss,	these	patients	exhibited	normal	patterns	of	
functional	connectivity	between	the	primary	and	extrastriate	visual	cortex	
indicating	a	lack	of	cortical	reorganization.	This	is	perhaps	good	news,	since	this	
result	suggests	that	the	neural	systems	required	to	process	information	from	retinal	
implant	technologies	remain	intact	despite	having	been	deprived	of	visual	input	for	
extended	periods	of	time.		
	
In	the	final	paper	of	this	feature	issue,	Boucard	at	al	explore	the	impact	of	normal‐
tension	glaucoma	on	subcortical	white	matter	microstructure	using	diffusion	tensor	
imaging.		Glaucoma	is	of	particular	interest	from	a	brain	imaging	perspective	
because	the	neurodegenerative	effects	of	the	disease	extend	beyond	the	retinal	
ganglion	cells	to	the	lateral	geniculate	nucleus	and	cortex.17,	18	Boucard	et	al.	report	
evidence	of	white	matter	abnormalities	in	the	optic	radiations,	forceps	major	(a	
large	fiber	bundle	that	connects	the	two	occipital	lobes)	and	the	corpus	callosum	
(the	primary	white	matter	connection	between	the	two	hemispheres).	These	white	
matter	changes	may	reflect	neurodegeneration.	Therefore,	the	presence	of	white	
matter	changes	in	these	structures	that	are	remote	from	the	retinal	ganglion	cells	
raises	the	intriguing	possibility	that	glaucoma	may	involve	brain‐specific	
neurodegeneration.		
	
As	a	whole,	the	papers	that	make	up	this	feature	issue	highlight	how	rapid	
technological	advances	have	provided	us	with	the	ability	to	image	all	aspects	of	the	
visual	system	with	unprecedented	resolution.	The	expanding	capabilities	and	scope	
of	imaging	technologies	and	continued	multidisciplinary	approach	to	imaging	the	
eye	and	brain	promises	to	further	broaden	our	knowledge	of	the	entire	visual	
system:	from	the	anterior	eye,	to	the	retina	and	the	cerebral	cortex.	We	envision	
that	the	developments	in	imaging	on	the	horizon	have	the	potential	to	further	
transform	clinical	practice	and	patient	management	and	enable	continued	research	
breakthroughs	and	discoveries.	
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